Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 378024, 8 pages
http://dx.doi.org/10.1155/2014/378024
Research Article

Dietary Hyaluronic Acid Migrates into the Skin of Rats

1R&D Division, Kewpie Corporation, 2-5-7 Sengawa Kewport, Sengawa, Chofu, Tokyo 182-0002, Japan
2ADME & Tox. Research Institute, Sekisui Medical Co., Ltd., 2117 Muramatsu, Tokai-mura, Naka-gun, Ibaraki 319-1182, Japan

Received 8 May 2014; Revised 31 July 2014; Accepted 31 July 2014; Published 14 October 2014

Academic Editor: Enzo Berardesca

Copyright © 2014 Mariko Oe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. E. Fraser, T. C. Laurent, and U. B. G. Laurent, “Hyaluronan: its nature, distribution, functions and turnover,” Journal of Internal Medicine, vol. 242, no. 1, pp. 27–33, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Meyer and J. W. Palmer, “The polysaccharide of the vitreous humor,” The Journal of Biological Chemistry, vol. 107, pp. 629–634, 1934. View at Google Scholar
  3. R. Stern, “Hyaluronan catabolism: a new metabolic pathway,” European Journal of Cell Biology, vol. 83, no. 7, pp. 317–325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Oe, T. Yoshida, T. Kanemitsu et al., “Repeated 28-day oral toxicological study of hyaluronic acid in rats,” Pharmacometrics, vol. 81, no. 1/2, pp. 11–21, 2011 (Japanese). View at Google Scholar
  5. K. Miyoshi, T. Hasegawa, and M. Nakazawa, “Chronic toxicity test on sodium hyaluronate (SPH) in beagle dogs by intra-articular administration for 6 months and recovery test. (1) General findings,” Pharmacometrics, vol. 29, no. 1, pp. 49–81, 1985 (Japanese). View at Google Scholar · View at Scopus
  6. Y. Wakisaka, H. Eiro, H. Matsumoto et al., “Acute toxicity of sodium hyaluronate (SL-1010) in mice,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 7–12, 1991 (Japanese). View at Google Scholar · View at Scopus
  7. H. Y. Morita Kawakami, K. Shimomura, and M. Sunaga, “Acute toxicity study of sodium hyaluronate (SL-1010) in rats and dogs,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 13–18, 1991. View at Google Scholar · View at Scopus
  8. K. Nagano, S. goto, R. Okabe et al., “Acute toxicity test of sodium hyaluronate (SPH),” Japanese Pharmacology and Therapeutics, vol. 12, no. 12, pp. 37–45, 1984 (Japanese). View at Google Scholar
  9. H. Morita, K. Shimomura, S. Suzuki, M. Hirata, and H. Koizumi, “Thirteen-week subcutaneous toxicity study on sodium hyaluronate (SL-1010) with 4-week recovery test in dogs,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 53–80, 1991 (Japanese). View at Google Scholar · View at Scopus
  10. H. Morita, Y. Kawakami, S. Suzuki, M. Hirata, and H. Koizumi, “Thirteen-week subcutaneous toxicity study on sodium hyaluronate (SL-1010) with 4-week recovery test in rats,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 19–52, 1991 (Japanese). View at Google Scholar · View at Scopus
  11. T. Hasegawa, K. Miyoshi, A. Nomura, and M. Nakazawa, “Subacute toxicity test on sodium hyaluronate (SPH) in rats by intraperitoneal administration for 3 months and recovery test,” Pharmacometrics, vol. 28, no. 6, pp. 1021–1040, 1984 (Japanese). View at Google Scholar · View at Scopus
  12. C. Tanaka, H. Sasa, S. Hirama et al., “Reproductive and developmental toxicity studies of sodium hyaluronate (SL-1010) (I). Fertility study in rats,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 81–92, 1991 (Japanese). View at Google Scholar · View at Scopus
  13. C. Tanaka, H. Sasa, S. Hirama et al., “Reproductive and developmental toxicity studies of sodium hyaluronate (SL-1010) (II). Teratogenicity study in rats,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 93–110, 1991 (Japanese). View at Google Scholar · View at Scopus
  14. K. Wada, Y. Hashimoto, M. Mizutani, and C. Tanaka, “Reproductive and developmental toxicity studies of sodium hyaluronate (SL-1010) (III). Tertognicity study in rabbits,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 111–119, 1991 (Chinese). View at Google Scholar · View at Scopus
  15. C. Ono, A. Iwama, A. Kitsuya, and T. Nakamura, “Reproductive and developmental toxicity study on sodium hyaluronate (SH)—(1) Study on subcutaneous administration to rats during the period of organogenesis,” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 11–26, 1992 (Japanese). View at Google Scholar · View at Scopus
  16. C. Ono, Y. Fujiwara, S. Koura, H. Tsuchida, and T. Nakamura, “Reproductive and developmental toxicity study on sodium hyaluronate (SH)-(2) Study on subcutaneous administration to rats prior to and in the early stages of pregnancy,” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 27–35, 1992. View at Google Scholar · View at Scopus
  17. C. Ono, H. Ishitobi, K. Kuzuoka, S. Konagai, and T. Nakamura, “Reproductive and developmental toxicity study on sodium hyaluronate (SH)-(3) Study on subcutaneous administration to rats during the perinatal and lactation period,” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 37–50, 1992 (Japanese). View at Google Scholar · View at Scopus
  18. C. Tateda, S. Nagaoka, T. Nagai, and T. Nakamura, “Reproductive and developmental toxicity study on sodium hyaluronate (SH)-(4) study on subcutaneous administration to rabbits during the period of organogenesis,” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 51–58, 1992. View at Google Scholar · View at Scopus
  19. R. Kameji, S. Itokawa, C. Yamawaki et al., “Antigenicity tests on sodium hyaluronate (SL-1010) in rabbit,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 159–175, 1991 (Japanese). View at Google Scholar · View at Scopus
  20. M. Takemoto, Y. Ohzone, and K. Asahi, “Antigenicity test of sodium hyaluronate (SH),” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 59–64, 1992 (Japanese). View at Google Scholar · View at Scopus
  21. C. Sugiyama and O. Yagame, “Mutagenicity tests on sodium hyaluronate (SL-1010) (I). Reverse mutation test in bacteria,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 177–181, 1991 (Japanese). View at Google Scholar · View at Scopus
  22. C. Sugiyama and H. Kobayashi, “Mutagenicity tests on sodium hyaluronate (SL-1010) (II). In vitro cytogenetic test,” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 183–191, 1991 (Japanese). View at Google Scholar · View at Scopus
  23. M. Onishi, T. Nagata, K. Saigou, H. Sameshima, and R. Nagata, “Mutagenicity studies of sodium hyaluronate (SH),” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 65–72, 1992 (Japanese). View at Google Scholar · View at Scopus
  24. T. Hara, N. Horiya, M. Katoh, and T. Shibuya, “Micronucleus test in mice on sodium hyaluronate (SL-1010),” Japanese Pharmacology and Therapeutics, vol. 19, no. 1, pp. 193–197, 1991 (Japanese). View at Google Scholar · View at Scopus
  25. F. Aruga, Y. Miwa, T. Fuzimura, and S. Ohta, “Micronucleus test of sodium hyaluronate (SH) with mice,” Japanese Pharmacology and Therapeutics, vol. 20, no. 3, pp. 73–75, 1992 (Japanese). View at Google Scholar · View at Scopus
  26. T. Sato, T. Yoshida, T. Kanemitsu et al., “Clinical effect of hyaluronic acid diet for moisture content of dry skin,” Aesthe Derma, vol. 17, pp. 33–395, 2007 (Japanese). View at Google Scholar
  27. O. Kajimoto, W. Odanaka, W. Sakamoto et al., “Clinical effect of hyaluronic acid diet for dry skin-objective evaluation with microscopic skin surface analyzer,” Journal of New Remedies & Clinics, vol. 50, no. 5, pp. 548–560, 2001 (Japanese). View at Google Scholar
  28. T. Sato, W. Sakamoto, W. Odanaka et al., “Clinical effect of hyaluronic acid diet for dry and rough skin,” Aesthetic Dermatology, vol. 12, pp. 109–120, 2002. View at Google Scholar
  29. H. Hara, S. Haga, T. Kasai, and S. Kiriyama, “Fermentation products of sugar-beet fiber by cecal bacteria lower plasma cholesterol concentration in rats,” Journal of Nutrition, vol. 128, no. 4, pp. 688–693, 1998. View at Google Scholar · View at Scopus
  30. N. Hisada, H. Satsu, A. Mori et al., “Low-molecular-weight hyaluronan permeates through human intestinal Caco-2 cell monolayers via the paracellular pathway,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 4, pp. 1111–1114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Laznicek, A. Laznickova, D. Cozikova, and V. Velebny, “Preclinical pharmacokinetics of radiolabelled hyaluronan,” Pharmacological Reports, vol. 64, no. 2, pp. 428–437, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Balogh, A. Polyak, D. Mathe et al., “Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs,” Journal of Agricultural and Food Chemistry, vol. 56, no. 22, pp. 10582–10593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. G. S. Jones Jr., D. R. Elmaleh, H. W. Strauss, and A. J. Fischman, “7,10-Bis(2-mercapto-2-methyl)propyl-7,10-diazapalmitic acid: a novel, N2S2 ligand for technetium-99m,” Bioorganic and Medicinal Chemistry Letters, vol. 6, no. 20, pp. 2399–2404, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. R. M. Greco, J. A. Iocono, and H. P. Ehrlich, “Hyaluronic acid stimulates human fibroblast proliferation within a collagen matrix,” Journal of Cellular Physiology, vol. 177, no. 3, pp. 465–473, 1998. View at Google Scholar
  35. H. Lüke and P. Prehm, “Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells,” Biochemical Journal, vol. 343, no. 1, pp. 71–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. O. Ueda, M. Hasegawa, and S. Kitamura, “Distribution in skin of ceramide after oral administration to rats,” Drug Metabolism and Pharmacokinetics, vol. 24, no. 2, pp. 180–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Kawaguchi, P. N. Nanbu, and M. Kurokawa, “Distribution of prolylhydroxyproline and its metabolites after oral administration in rats,” Biological and Pharmaceutical Bulletin, vol. 35, no. 3, pp. 422–427, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Sasaki, E. Tsuda, Y. Yamamoto et al., “Serum hyaluronan levels increase with the total number of osteoarthritic joints and are strongly associated with the presence of knee and finger osteoarthritis,” International Orthopaedics, vol. 35, no. 5, pp. 925–930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Cozikova, A. Laznickova, M. Hermannova et al., “Preparation and the kinetic stability of hyaluronan radiolabeled with 111In, 125I and 14C,” Journal of Pharmaceutical and Biomedical Analysis, vol. 52, no. 4, pp. 517–524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. G. L. Grove and A. M. Kligman, “Age-associated changes in human epidermal cell renewal,” Journals of Gerontology, vol. 38, no. 2, pp. 137–142, 1983. View at Google Scholar · View at Scopus
  41. G. I. Frost, A. B. Csóka, T. Wong, and R. Stern, “Purification, cloning, and expression of human plasma hyaluronidase,” Biochemical and Biophysical Research Communications, vol. 236, no. 1, pp. 10–15, 1997. View at Google Scholar
  42. G. Lepperdinger, B. Strobl, and G. Kreil, “HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity,” Journal of Biological Chemistry, vol. 273, no. 35, pp. 22466–22470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Sato, T. Takahashi, H. Ide et al., “Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients,” Arthritis & Rheumatism, vol. 31, no. 1, pp. 63–70, 1988. View at Publisher · View at Google Scholar · View at Scopus
  44. J. D. McNeil, O. W. Wiebkin, W. H. Betts, and L. G. Cleland, “Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals,” Annals of the Rheumatic Diseases, vol. 44, no. 11, pp. 780–789, 1985. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Yamazaki, K. Fukuda, M. Matsukawa et al., “Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical,” Pathophysiology, vol. 9, no. 4, pp. 215–220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. L. Hawkins and M. J. Davies, “Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials,” Free Radical Biology and Medicine, vol. 21, no. 3, pp. 275–290, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. U. M. Ågren, R. H. Tammi, and M. I. Tammi, “Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture,” Free Radical Biology and Medicine, vol. 23, no. 7, pp. 996–1001, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Zhou, J. A. Weigel, L. Fauss, and P. H. Weigel, “Identification of the hyaluronan receptor for endocytosis (HARE),” Journal of Biological Chemistry, vol. 275, no. 48, pp. 37733–37741, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Eriksson, J. R. E. Fraser, T. C. Laurent, H. Pertoft, and B. Smedsrød, “Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver,” Experimental Cell Research, vol. 144, no. 1, pp. 223–228, 1983. View at Publisher · View at Google Scholar · View at Scopus
  50. I. Setnikar and L. C. Rovati, “Absorption, distribution, metabolism and excretion of glucosamine sulfate: a review,” Arzneimittel-Forschung, vol. 51, no. 9, pp. 699–725, 2001. View at Google Scholar · View at Scopus
  51. M. O. Longas, C. S. Russell, and X. Y. He, “Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging,” Carbohydrate Research, vol. 159, no. 1, pp. 127–136, 1987. View at Publisher · View at Google Scholar · View at Scopus